Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TP53 DNA binding domain mutational status and rituximab-based treatment are independent prognostic factors for pediatric Burkitt lymphoma patients stratification.
Martire G, Lovisa F, Carraro E, Rizzato D, Cesaro S, Mura RM, Tondo A, Bertolin C, Boaretto F, Salviati L, Biffi A, Pillon M, Mussolin L. Martire G, et al. Among authors: tondo a. Haematologica. 2024 Feb 22. doi: 10.3324/haematol.2023.284868. Online ahead of print. Haematologica. 2024. PMID: 38385281 Free article.
Non-Hodgkin lymphoma in children with an associated inherited condition: A retrospective analysis of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
Aricò M, Mussolin L, Carraro E, Buffardi S, Santoro N, D'Angelo P, Lombardi A, Pierani P, Giraldi E, Mura R, Sala A, Garaventa A, Tondo A, Piglione M, Lo Nigro L, Cesaro S, Perruccio K, Rosolen A, Basso G, Pillon M; NHL-Committee of the Italian Association of Pediatric Hematology Oncology. Aricò M, et al. Among authors: tondo a. Pediatr Blood Cancer. 2015 Oct;62(10):1782-9. doi: 10.1002/pbc.25565. Epub 2015 May 22. Pediatr Blood Cancer. 2015. PMID: 26011068
Detection of prognostic factors in children and adolescents with Burkitt and Diffuse Large B-Cell Lymphoma treated with the AIEOP LNH-97 protocol.
Pillon M, Mussolin L, Carraro E, Conter V, Aricò M, Vinti L, Garaventa A, Piglione M, Buffardi S, Sala A, Santoro N, Lo Nigro L, Mura R, Tondo A, Casale F, Farruggia P, Pierani P, Cesaro S, d'Amore ES, Basso G. Pillon M, et al. Among authors: tondo a. Br J Haematol. 2016 Nov;175(3):467-475. doi: 10.1111/bjh.14240. Epub 2016 Jul 8. Br J Haematol. 2016. PMID: 27392319 Free article.
Clinical Characteristics and Outcome of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Italian Pediatric Oncology Patients: A Study From the Infectious Diseases Working Group of the Associazione Italiana di Oncologia e Ematologia Pediatrica.
Bisogno G, Provenzi M, Zama D, Tondo A, Meazza C, Colombini A, Galaverna F, Compagno F, Carraro F, De Santis R, Meneghello L, Baretta V, Cesaro S. Bisogno G, et al. Among authors: tondo a. J Pediatric Infect Dis Soc. 2020 Nov 10;9(5):530-534. doi: 10.1093/jpids/piaa088. J Pediatric Infect Dis Soc. 2020. PMID: 32652521 Free PMC article.
Quantification of Minimal Disease by Digital PCR in ALK-Positive Anaplastic Large Cell Lymphoma: A Step towards Risk Stratification in International Trials?
Damm-Welk C, Lovisa F, Contarini G, Lüdersen J, Carraro E, Knörr F, Förster J, Zimmermann M, Sala A, Vinti L, Tondo A, Pillon M, Woessmann W, Mussolin L. Damm-Welk C, et al. Among authors: tondo a. Cancers (Basel). 2022 Mar 27;14(7):1703. doi: 10.3390/cancers14071703. Cancers (Basel). 2022. PMID: 35406475 Free PMC article.
Outcome of primary hemophagocytic lymphohistiocytosis: a report on 143 patients from the Italian Registry.
Pegoraro F, Chinnici A, Beneforti L, Tanturli M, Trambusti I, De Fusco C, Micalizzi C, Barat V, Cesaro S, Gaspari S, Dell'Acqua F, Todesco A, Timeus F, Aricò M, Favre C, Tondo A, Coniglio ML, Sieni E; AIEOP Histiocytosis Working Group. Pegoraro F, et al. Among authors: tondo a. Haematologica. 2024 Feb 22. doi: 10.3324/haematol.2023.283893. Online ahead of print. Haematologica. 2024. PMID: 38385274 Free article.
Metastatic neuroblastoma in infants: are survival rates excellent only within the stringent framework of clinical trials?
Di Cataldo A, Agodi A, Balaguer J, Garaventa A, Barchitta M, Segura V, Bianchi M, Castel V, Castellano A, Cesaro S, Couselo JM, Cruz O, D'Angelo P, De Bernardi B, Donat J, de Andoin NG, Hernandez MI, La Spina M, Lillo M, Lopez-Almaraz R, Luksch R, Mastrangelo S, Mateos E, Molina J, Moscheo C, Mura R, Porta F, Russo G, Tondo A, Torrent M, Vetrella S, Villegas JA, Viscardi E, Zanazzo GA, Cañete A. Di Cataldo A, et al. Among authors: tondo a. Clin Transl Oncol. 2017 Jan;19(1):76-83. doi: 10.1007/s12094-016-1505-1. Epub 2016 Apr 4. Clin Transl Oncol. 2017. PMID: 27041689
Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children.
Minard-Colin V, Aupérin A, Pillon M, Burke GAA, Barkauskas DA, Wheatley K, Delgado RF, Alexander S, Uyttebroeck A, Bollard CM, Zsiros J, Csoka M, Kazanowska B, Chiang AK, Miles RR, Wotherspoon A, Adamson PC, Vassal G, Patte C, Gross TG; European Intergroup for Childhood Non-Hodgkin Lymphoma; Children’s Oncology Group. Minard-Colin V, et al. N Engl J Med. 2020 Jun 4;382(23):2207-2219. doi: 10.1056/NEJMoa1915315. N Engl J Med. 2020. PMID: 32492302 Free PMC article. Clinical Trial.
67 results